BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25311280)

  • 1. Mapping ventricular expansion onto cortical gray matter in older adults.
    Madsen SK; Gutman BA; Joshi SH; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S32-41. PubMed ID: 25311280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of gray matter microstructural changes in Alzheimer's disease continuum using fiber orientation.
    Lee P; Kim HR; Jeong Y;
    BMC Neurol; 2020 Oct; 20(1):362. PubMed ID: 33008321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.
    Madsen SK; Rajagopalan P; Joshi SH; Toga AW; Thompson PM;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S203-10. PubMed ID: 25444607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.
    Luis EO; Ortega-Cubero S; Lamet I; Razquin C; Cruchaga C; Benitez BA; Lorenzo E; Irigoyen J; ; Pastor MA; Pastor P
    Neurobiol Aging; 2014 Dec; 35(12):2681-2690. PubMed ID: 25027412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease.
    Apostolova LG; Green AE; Babakchanian S; Hwang KS; Chou YY; Toga AW; Thompson PM
    Alzheimer Dis Assoc Disord; 2012; 26(1):17-27. PubMed ID: 22343374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease.
    Babiloni C; Carducci F; Lizio R; Vecchio F; Baglieri A; Bernardini S; Cavedo E; Bozzao A; Buttinelli C; Esposito F; Giubilei F; Guizzaro A; Marino S; Montella P; Quattrocchi CC; Redolfi A; Soricelli A; Tedeschi G; Ferri R; Rossi-Fedele G; Ursini F; Scrascia F; Vernieri F; Pedersen TJ; Hardemark HG; Rossini PM; Frisoni GB
    Hum Brain Mapp; 2013 Jun; 34(6):1427-46. PubMed ID: 22331654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients.
    Wirth M; Pichet Binette A; Brunecker P; Köbe T; Witte AV; Flöel A
    J Cereb Blood Flow Metab; 2017 Mar; 37(3):814-824. PubMed ID: 27037094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential microstructural and morphological abnormalities in mild cognitive impairment and Alzheimer's disease: Evidence from cortical and deep gray matter.
    Gong NJ; Chan CC; Leung LM; Wong CS; Dibb R; Liu C
    Hum Brain Mapp; 2017 May; 38(5):2495-2508. PubMed ID: 28176436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter volume and estimated brain age gap are not linked with sleep-disordered breathing.
    Mohajer B; Abbasi N; Mohammadi E; Khazaie H; Osorio RS; Rosenzweig I; Eickhoff CR; Zarei M; Tahmasian M; Eickhoff SB;
    Hum Brain Mapp; 2020 Aug; 41(11):3034-3044. PubMed ID: 32239749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    van de Mortel LA; Thomas RM; van Wingen GA;
    J Alzheimers Dis; 2021; 83(2):705-720. PubMed ID: 34366336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample.
    Riverol M; Ríos-Rivera MM; Imaz-Aguayo L; Solis-Barquero SM; Arrondo C; Montoya-Murillo G; Villino-Rodríguez R; García-Eulate R; Domínguez P; Fernández-Seara MA
    Neuroimage Clin; 2024; 42():103615. PubMed ID: 38749146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M; Egger K; Marksteiner J; Esterhammer R; Hinterhuber H; Deisenhammer EA; Schocke M
    PLoS One; 2014; 9(8):e106062. PubMed ID: 25153085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Dadar M; Manera AL; Ducharme S; Collins DL
    Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.
    Prestia A; Baglieri A; Pievani M; Bonetti M; Rasser PE; Thompson PM; Marino S; Bramanti P; Frisoni GB
    Suppl Clin Neurophysiol; 2013; 62():67-80. PubMed ID: 24053032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
    Knopman DS; Jack CR; Lundt ES; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
    JAMA Neurol; 2015 Dec; 72(12):1475-83. PubMed ID: 26437123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.